Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about SPECTRUM PHARMACEUTICALS, INC.
01/20Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Co..
BU
01/06SPECTRUM PHARMACEUTICALS : Announces New Strategic Investment by Hanmi Pharmaceutical - Fo..
PU
01/06SPECTRUM PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unregistered Sa..
AQ
01/05Spectrum Pharmaceuticals to Cut 30% of Staff, Prioritize Late-Stage Programs in Restruc..
MT
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
BU
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
CI
01/04Spectrum Pharmaceuticals to Get $20 Million Equity Investment from Hanmi Pharmaceutical
MT
01/04Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
BU
01/04Spectrum Pharmaceuticals, Inc. announced that it expects to receive $20 million in fund..
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from S&P Biotechnology Select Industr..
CI
2021SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
2021Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib to US Food and Dru..
MT
2021Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
BU
2021SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)
AQ
2021Spectrum Pharmaceuticals CEO Agrees to Retire, COO Named Successor From Dec. 31
MT
2021Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
BU
2021Spectrum Pharmaceuticals, Inc. Announces Appointment of Tom Riga as President and CEO, ..
CI
2021Spectrum Pharmaceuticals, Inc. Announces Changes to Board of Directors
CI
2021Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summi..
BU
2021Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
BU
2021Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Upd..
PU
2021Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
2021SPECTRUM PHARMA : Q3 Earnings Snapshot
AQ
2021Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Upd..
BU
2021Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Cor..
BU
2021SHAREHOLDER ALERT : Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Mis..
BU
2021SPECTRUM PHARMACEUTICALS : Pharma's Poziotinib Combo Shows 'Promising' Data in Preclinical..
MT
2021AACR-NTI-EROTC VIRTUAL INTERNATIONAL : Pan-ErbB inhibition enhances activity of KRASG12C i..
PU
2021SPECTRUM PHARMACEUTICALS : Announces Presentation of Poziotinib in Combination with KRASG1..
BU
2021Spectrum Pharmaceuticals Announces Presentation of Poziotinib in Combination with KRASG..
CI
2021SHAREHOLDER ALERT : Robbins LLP Reminds Investors that Spectrum Pharmaceuticals, Inc. (SPP..
BU
2021SPECTRUM PHARMACEUTICALS : to Participate in 2021 Cantor Virtual Global Healthcare Confere..
BU
2021ESMO CONGRESS 2021 : Efficacy and Safety of Poziotinib in Treatment-naïve NSCLC Harboring ..
PU
2021SPECTRUM PHARMACEUTICALS : Presents Late Breaker Oral Presentation of Poziotinib Data in F..
BU
2021Spectrum Pharmaceuticals, Inc. Presents Late Breaker Oral Presentation of Poziotinib Da..
CI
2021SPECTRUM PHARMACEUTICALS : Announces Late-Breaking Oral Presentation of Data for Poziotini..
BU
2021SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
2021SHAREHOLDER ALERT : Robbins LLP Announces that Spectrum Pharmaceuticals, Inc. (SPPI) is Be..
BU
2021GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Spectrum Pharmaceuticals, In..
BU
2021INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Spectrum Pharma..
BU
2021SPECTRUM PHARMACEUTICALS : B. Riley Lowers Spectrum Pharmaceuticals' PT to $6 from $8 on '..
MT
2021SPECTRUM PHARMA : Q2 Earnings Snapshot
AQ
2021SPECTRUM PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and..
AQ
2021SPECTRUM PHARMACEUTICALS : The company is requesting a meeting with the FDA to clarify the..
PU
2021SPECTRUM PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Corporate Upd..
BU
2021Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
CI
2021SPECTRUM ALERT : Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, In..
BU
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spect..
PR
2021Top Midday Decliners
MT
2021(SPPI) ALERT : Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Inv..
PR
2021SPECTRUM PHARMACEUTICALS : Says FDA Rejects Application for Neutropenia Drug Candidate; Sh..
MT
2021Wall Street Sees Narrowly Mixed Open, Strong Jobs Data in Focus
MT
2021Spectrum Pharma Shares Tumble as FDA Turns Away Rolontis Application
DJ
2021Top Premarket Decliners
MT
2021SPECTRUM PHARMACEUTICALS : Receives Complete Response Letter from FDA for ROLONTIS« (eflap..
BU
2021Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS« (efla..
CI
2021FDA Rejects Spectrum's Rolontis Due to Manufacturing Issues
DJ
2021SPECTRUM PHARMACEUTICALS : to Report Second Quarter 2021 Financial Results and Provide Cor..
BU
2021SPECTRUM PHARMACEUTICALS : Files for Up to $300 Million Mixed-Securities Shelf
MT
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 3000 Value Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 3000E Growth Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell Microcap Value Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 2500 Growth Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 3000 Growth Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell Small Cap Comp Value Ind..
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell Microcap Growth Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 3000E Value Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell Small Cap Comp Growth Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 2500 Value Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 2000 Growth Index
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 2000 Value Index
CI
2021SPECTRUM PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders, Financ..
AQ
2021SPECTRUM PHARMACEUTICALS : Reports Data From First 3 Cohorts of Poziotinib Lung Cancer Tri..
MT
20212021 ASCO ANNUAL MEETING : CNS activity of poziotinib in NSCLC with exon 20 insertion muta..
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SPECTRUM PHARMACEUTICALS, INC.
03/09/22